| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9975252 | The Journal of Heart and Lung Transplantation | 2005 | 8 Pages |
Abstract
Relatively high-dose CsA mitigated parenchymal rejection and GCAD of the mouse cardiac allografts. In addition, a valuable mouse model mimicking the clinical course of GCAD was achieved with CsA treatment of 20 mg/kg/day for 30 days.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Masashi MD, Golnaz K. MD, Leora B. MD, David T. MD, Theo MD, Monika MD, Robert C. MD,